Living close to urban green spaces is associated with decreased breast cancer risk

by Barcelona Institute for Global Health (ISGlobal)Credit: CC0 Public DomainAn increasing number of studies are reporting the health benefits of contact with urban green spaces. A new study from the B

Updated on: April 07,2024

Living close to urban green spaces is associated with decreased breast cancer risk

by Barcelona Institute for Global Health (ISGlobal)Credit: CC0 Public DomainAn increasing number of studies are reporting the health benefits of contact with urban green spaces. A new study from the B

Updated on:April 07,2024

Tracking the epigenetic evolution of a cancer, cell by cell

by Weill Cornell Medical CollegeDr. Dan Landau. Credit: Rene PerezA powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables

Updated on: May 23,2024

Tracking the epigenetic evolution of a cancer, cell by cell

by Weill Cornell Medical CollegeDr. Dan Landau. Credit: Rene PerezA powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables

Updated on:May 23,2024

Long-term conditions could delay lung cancer diagnosis, new study finds

byUniversity of SussexMedian diagnostic interval by number of AE and CD conditions. Credit:British Journal of Cancer(2024). DOI: 10.1038/s41416-024-02824-2A new study from researcher

Updated on: September 07,2024

Long-term conditions could delay lung cancer diagnosis, new study finds

byUniversity of SussexMedian diagnostic interval by number of AE and CD conditions. Credit:British Journal of Cancer(2024). DOI: 10.1038/s41416-024-02824-2A new study from researcher

Updated on:September 07,2024

A new method for conducting a liquid biopsy for liver cancer

by Bob Yirka , Medical XpressComparison between mutation and methylation fractions in the same cfDNA sample. (A) The correlation between the AF based on mutation and methylation. (B) Comparison of the

Updated on: January 30,2024

A new method for conducting a liquid biopsy for liver cancer

by Bob Yirka , Medical XpressComparison between mutation and methylation fractions in the same cfDNA sample. (A) The correlation between the AF based on mutation and methylation. (B) Comparison of the

Updated on:January 30,2024

New spatial tool shows cancer cells rev up synthesis, compared with neighbors

by Talia Ogliore,Washington University in St. LouisMass spectrometry imaging with stable isotope labeling workflow.aMice with orthotopic brain tumors were fed an unlabeled or U−13C g

Updated on: January 12,2024

New spatial tool shows cancer cells rev up synthesis, compared with neighbors

by Talia Ogliore,Washington University in St. LouisMass spectrometry imaging with stable isotope labeling workflow.aMice with orthotopic brain tumors were fed an unlabeled or U−13C g

Updated on:January 12,2024

Researchers to investigate screening for prostate cancer using MRI—potentially replacing the PSA test

by Medical Research CouncilCredit: Medical Research CouncilA new clinical study will test for the first time if MRI scans can be used for population screening to detect prostate cancer more accur

Updated on: March 06,2024

Researchers to investigate screening for prostate cancer using MRI—potentially replacing the PSA test

by Medical Research CouncilCredit: Medical Research CouncilA new clinical study will test for the first time if MRI scans can be used for population screening to detect prostate cancer more accur

Updated on:March 06,2024

Use of MMR deficiency testing in younger CRC patients is low

(HealthDay)—Fewer than half of younger adults with colorectal cancer (CRC) undergo mismatch repair (MMR) deficiency of DNA testing, according to a study published online Nov. 9 inJAMA Oncology.T

Updated on: April 22,2024

Use of MMR deficiency testing in younger CRC patients is low

(HealthDay)—Fewer than half of younger adults with colorectal cancer (CRC) undergo mismatch repair (MMR) deficiency of DNA testing, according to a study published online Nov. 9 inJAMA Oncology.T

Updated on:April 22,2024

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee

Updated on: March 30,2024

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee

Updated on:March 30,2024

Study identifies a potential therapeutic target for triple-negative breast cancer in Black patients

by Adam Pope,University of Alabama at BirminghamProtein diversity due to alternative mRNA splicing or post-translational modifications (PTMs) plays a vital role in various cellular functions. Th

Updated on: February 18,2024

Study identifies a potential therapeutic target for triple-negative breast cancer in Black patients

by Adam Pope,University of Alabama at BirminghamProtein diversity due to alternative mRNA splicing or post-translational modifications (PTMs) plays a vital role in various cellular functions. Th

Updated on:February 18,2024

Study fingers new player in cancer immunity

by Harvard Medical SchoolKiller T cells surround a cancer cell. Credit: NIHThe immune system must strike an exquisite balance between vanquishing infections and cancer, while at the same time res

Updated on: May 25,2024

Study fingers new player in cancer immunity

by Harvard Medical SchoolKiller T cells surround a cancer cell. Credit: NIHThe immune system must strike an exquisite balance between vanquishing infections and cancer, while at the same time res

Updated on:May 25,2024

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an accepta

Updated on: September 27,2024

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an accepta

Updated on:September 27,2024

Study explores why patients skip appointments for suspected cancer

by Shelley Hughes,University of YorkCredit: CC0 Public DomainMen, the elderly and people from deprived areas are among the patients most likely to miss an urgent referral appointment for suspect

Updated on: May 21,2024

Study explores why patients skip appointments for suspected cancer

by Shelley Hughes,University of YorkCredit: CC0 Public DomainMen, the elderly and people from deprived areas are among the patients most likely to miss an urgent referral appointment for suspect

Updated on:May 21,2024